Search
Education
More information about educational initiatves and affiliated courses at the Golub Center.
6 arguments for carbon taxes
By
Long touted by economists, carbon taxes are transparent, enforceable, and adjustable. An MIT Sloan finance professor explains her support.
Crowdsourcing to better forecast drug approvals
Researchers launched an in-house Data Science and Artificial Intelligence (DSAI) challenge to beat MIT’s machine-learning models for predicting clinical trial outcomes. The results are now available.
Golub Center names Stanley Fischer winner of first Miriam Pozen Prize
By
$200,000 prize will be awarded to Dr. Fischer and a fellowship named in his honor will be awarded to an MIT Sloan MBA student; Dr. Fischer will deliver the inaugural Miriam Pozen Address at MIT.
MIT’s Golub Center for Finance and Policy names judges for the Miriam Pozen Prize
By
Judges are Mohamed A. El-Erian, Kristin J. Forbes, Deborah J. Lucas, Robert C. Merton, Ronald P. O’Hanley, Henry M. Paulson, Jr., Raghuram R. Rajan, and Robert Zoellick.
BlackRock CEO: Don't divest fossil fuels, stay in the game
By
“Climate risk is investment risk.” BlackRock CEO Larry Fink shares his thoughts on how to create a net zero carbon world by 2050.
Growing importance of academia in accelerating biomedical innovation
By
MIT researchers have developed a methodology for systematically tracking the outcomes of academic licensing transactions as a means of increasing funding to bridging the “valley of death.”
Gamification techniques to improve online teaching and learning
By
A new study led by MIT Sloan Prof. Andrew W. Lo finds that borrowing ideas and tools from the gaming community can improve online teaching techniques and improve learning outcomes for students.
New statistical approach to COVID-19 clinical trials aims to accelerate drug approval process and attract more funding
By
The studies describe new methods for accelerating drug approvals during pandemics and for providing more accurate measures of the probabilities of success for clinical trials of vaccines.